Coronavirus: Oxford vaccine triggers immune response

sfg-2026
ForumIAS LATEST
    1. 5 August | Toppers Wrote 1000 Answers Between Prelims & Mains! | Click Here to Watch →
    2. 5 August | Are you the Average of the 5 People Around You by Mr. Ayush Sinha | Click Here to Watch →
    3. 5 August | First UPSC Mains Don't Chase AIR 1 by Mr Ayush Sinha | Click Here to Watch →

News: The human trial of COVID-19 vaccine named ChAdOx1 nCoV-19 vaccine developed by the University of Oxford and backed by AstraZeneca Plc has shown a positive result.

Facts:

  • How was the vaccine produced? The vaccine was made from a genetically engineered virus(adenovirus) that causes the common cold in chimpanzees.
    • However, the virus was heavily modified so that it cannot cause infections in people and look a bit like the coronavirus that produces spike protein that the virus uses to enter and infect human cells.
  • What was the response? The first phase of clinical trials did not prompt any serious side effects and produced antibodies and T-cells that can fight coronavirus.

Additional Facts:

  • Antibodies: It is a protective protein produced by the immune system in order to attack antigens.Antigen is a toxin or other foreign substance which induces an immune response in the body.
  • T-cells: It is a type of white blood cell that helps coordinate the immune system and are able to spot which of the body’s cells have been infected and destroy them.
Print Friendly and PDF
Blog
Academy
Community